Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., trading under the ticker HSAQ, is a blank-check company that completed its SPAC initial public offering in 2021, targeting the healthcare and medical technology sector. The company filed a Form 10-Q with the SEC on May 13, 2022, covering its first fiscal quarter, reflecting its status as an active special purpose acquisition company in the pre-merger search phase. Orchestra BioMed ultimately pursued a combination in the cardiovascular medical device space, with the SPAC structure designed to bring an innovative therapy platform to the public markets. For complete filing history, sponsor details, merger timeline, and deal analytics on HSAQ, sign up for full access at SpacDesk.